Chalabi, Myriam http://orcid.org/0000-0002-8607-6174
Fanchi, Lorenzo F.
Dijkstra, Krijn K.
Van den Berg, José G.
Aalbers, Arend G.
Sikorska, Karolina
Lopez-Yurda, Marta
Grootscholten, Cecile
Beets, Geerard L. http://orcid.org/0000-0002-1671-9912
Snaebjornsson, Petur http://orcid.org/0000-0002-1086-8108
Maas, Monique
Mertz, Marjolijn
Veninga, Vivien
Bounova, Gergana
Broeks, Annegien
Beets-Tan, Regina G.
de Wijkerslooth, Thomas R.
van Lent, Anja U.
Marsman, Hendrik A.
Nuijten, Elvira
Kok, Niels F.
Kuiper, Maria
Verbeek, Wieke H.
Kok, Marleen http://orcid.org/0000-0001-9043-9815
Van Leerdam, Monique E.
Schumacher, Ton N. http://orcid.org/0000-0003-0517-8804
Voest, Emile E. http://orcid.org/0000-0001-8249-9586
Haanen, John B. http://orcid.org/0000-0001-5884-7704
Article History
Received: 27 May 2019
Accepted: 18 February 2020
First Online: 6 April 2020
Competing interests
: L.F.F., K.K.D., J.G.V.d.B., A.G.A., M.L.-Y., K.S., C.G., G.L.B., P.S., M. Mertz, V.V., G.B., A.B., R.G.B.-T., T.R.d.W., A.U.v.L., H.A.M., M. Maas, E.N., N.F.K., W.H.V., A.U.v.L., M. Kuiper and M.E.V.L. have no competing interests to declare. M.C. reports funding to the institute from BMS and Roche/Genentech and an advisory role for BMS, outside the submitted work. M. Kok reports funding to the institute from BMS, Roche/Genentech, AZ and an advisory role for BMS and Daiichi Sankyo, outside the submitted work. J.B.H. reports institutional fees for advisory roles from BMS, Merck, Roche, Neon therapeutics, Pfizer and Ipsen and NKI, and received grants from BMS, Merck, Novartis and Neon Therapeutics, outside the submitted work. E.E.V. reports research funding from BMS, outside the submitted work. T.N.S. is a consultant for Adaptive Biotechnologies, AIMM Therapeutics, Allogene Therapeutics, Amgen, Merus, Neon Therapeutics, Scenic Biotech; Grant/Research support are from: Merck, Bristol-Myers-Squibb, Merck KGaA; stockholder in: AIMM Therapeutics, Allogene Therapeutics, Neon Therapeutics, all outside the submitted work.